Cysteine Market size was over USD 403.89 billion in 2024 and is poised to exceed USD 882.84 billion by 2037, witnessing over 6.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of pet tech is estimated at USD 423.92 billion. The market is estimated to grow on the back of increasing demand for cysteine from the pharmaceutical industry. In the pharmaceutical industry, cysteine used to make its derivatives, which are further used as a processing aid in refolding of genetically modified proteins. Therefore, the growth of the pharmaceutical industry is anticipated to provide lucrative growth opportunities to the global cysteine market in the coming years. According to the data, under the Strengthening Pharmaceutical Industry (SPI) scheme in India, a financial outlay of about USD 660 million was announced for the further development of the pharmaceutical industry for the period from 2021-22 to 2025-26.
The global cysteine market is also estimated to witness noteworthy growth over the forecast period on the back of the rising adoption of cysteine from the cosmetic industry, as it is highly used as an anti-agent. It was observed that more than 45 billion are produced from cosmetic sales in the United States each year. The rising identification and detection of diseases or disorders caused by cysteine ​​deficiency in the human body is also expected to boost market growth during the forecast period. Moreover, rising health awareness and an increasing proportion of disposable income are also projected to drive the growth of the global cysteine market in the coming years.
Growth Drivers
In the bakery industry, cysteine is used as a dough conditioner to break down gluten disulfide bonds. It is helpful to reduce the dough viscosity and increase the elasticity so it’ll get puffed up during baking. Furthermore, there are no significant health issues associated with the utilization of cysteine. Cysteine is not considered to be a vegetarian source, hence, not appropriate to be consumed by vegans. The increasing consumption of bakery products is expected to increase the demand for cysteine from the bakery industry over the forecast period.
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.2% |
|
Base Year Market Size (2024) |
USD 403.89 billion |
|
Forecast Year Market Size (2037) |
USD 882.84 billion |
|
Regional Scope |
|
End-user (Food, Pharmaceutical, Animal Feed)
The global cysteine market is segmented and analyzed for demand and supply by end-use industry into food, pharmaceutical, animal feed, and others. Out of these four segments, the food segment is estimated to gain the largest market share in the year 2037. The growth of the segment can be attributed to the increasing growth and sales of the food and beverages industry. According to the data, about USD 2.1 trillion of food was supplied by the food retail and food service industry in 2021, of which about USD 1.1 trillion worth of food was supplied by food service facilities. Cysteine ​​is widely used as a process of flavoring in the food industry and is mostly adopted when preparing meat seasonings and roasting flavors. In addition, the increased consumption rate of food and health care supplements in the day-to-day diet are also projected to support the growth of this segment in the coming years.
Application (Conditioner, Flavor Enhancer, Reducing Agent, Production of Human Insulin)
The global cysteine market is also segmented and analyzed for demand and supply by application into conditioners, flavor enhancers, reducing agents, production of human insulin, and others. Cysteine is considered to be the most useful protein for hair and gets dissolved with other proteins already present in the hair. It can make the hair look softer and makes hair curl-free. Cysteine creates a protective shield around the hair to prevent any sort of damage. It is projected to prevent certain hair diseases such as androgenetic alopecia, hair shaft breakage, alopecia areata, telogen & anagen effluvium, and others. It was observed that around 30 million women and 45 million men suffer from androgenetic alopecia. Androgenetic alopecia common disease that causes hair loss at a rapid pace. This disease is considered to be hereditary and is also treated with surgery and medication.
Our in-depth analysis of the global cysteine market includes the following segments:
|
By Production Process |
|
|
By Application |
|
|
By End Use Industry |
|
APAC Market Statistics
Asia Pacific industry is expected to hold largest revenue share of 38% by 2037. In India, the bakery industry is increasing its expansion and the demand for cysteine ​​from the bakery industry is also expected to increase owing to dough conditioning and other applications. Moreover, increasing production of biscuits and cookies is also estimated to drive the growth of the global cysteine market in the region during the forecast period. According to statistics, around 630 thousand metric tons of biscuits and cookies were produced in the South Asian country of India in 2020. It shows that there is a huge demand for cysteine in the production of snack food such as biscuits, pastries, and others. For instance, between 2023 to 2027, the snack food segment in Asia is projected to grow by approximately 6% summing up to a total volume of USD 300 billion in 2027.
North American Market Forecast
The North American cysteine market is estimated to register significant growth during the forecast period. The growth of the market can be attributed majorly to the increasing level of the geriatric population with osteogenesis imperfecta needing anti-aging components and the growth of the pharmaceutical industry in the region boosting the demand for cysteine. It was noticed that in 2019, there were approximately 53 million people over the age of 65 in the United States, representing about 16% of the population, which is projected to reach 21% by 2040. Hence, such factors are estimated to drive the growth of the market in the region during the forecast period.
Exela Pharma Sciences, LLC, a leading healthcare products provider, today announced the launch of ELCYS (cysteine hydrochloride injection), the only FDA-approved cysteine hydrochloride injection available in the United States market.
Wacker Chemie AG, the life science division of the WACKER group, has started the production line for cysteine in Spain. The new site aims to produce cysteine resulting from fermentation to meet growing global customer demand.
Author Credits: Rajrani Baghel
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?